Live Chat ×
Skip to main content

Small Lung Biopsies and FNAs for Molecular/FISH Work-Up


Evaluated by:  David B. Kaminsky, M.D., FIAC, March 21, 2018
Original release date: May 29, 2018
Access to this course expires on:  March 21, 2021
CME/SAMs 0.75

Faculty: Carol Farver, M.D., Jennifer Brainard, M.D.

Learning Objectives:
  • Define the pathologic features that dictate the use of molecular testing in the non-small cell lung cancer.
  • Define the pathologic features that dictate the use of immunohistochemistry in the pathologic diagnosis of non-small cell lung cancer.
  • Define the techniques used to identify the EML4/ALK rearrangement in lung cancer tissue specimens.
  • Define the gene that has the most common targetable mutation in lung cancer.